Rockwell Medical, Inc. (RMTI): Revenue
$69.26M
Year ended 2025-12-31
$69.39M
Trailing 12 months to 2026-06-30
-1.7%
3-year compound annual growth
+2.2%
5-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $69.26M | -31.8% | 2026-03-26, From 2025-01-01 |
| 2024-12-31 | $101.49M | +21.4% | 2026-03-26, From 2024-01-01 |
| 2023-12-31 | $83.61M | +14.8% | 2025-03-20, From 2023-01-01 |
| 2022-12-31 | $72.81M | +17.6% | 2024-03-21, From 2022-01-01 |
| 2021-12-31 | $61.93M | -0.4% | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | $62.20M | +1.5% | 2022-04-08, From 2020-01-01 |
| 2019-12-31 | $61.30M | -3.3% | 2021-03-31, From 2019-01-01 |
| 2018-12-31 | $63.39M | +10.6% | 2020-03-17, From 2018-01-01 |
| 2017-12-31 | $57.30M | n/a | 2019-03-18, From 2017-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| Rockwell Medical, Inc. (RMTI) | 2025-12-31 | $69.26M | -31.8% |
| Viridian Therapeutics, Inc. (VRDN) | 2025-12-31 | $70.85M | n/m |
| Kura Oncology, Inc. (KURA) | 2025-12-31 | $67.48M | +25.2% |
| Spero Therapeutics, Inc. (SPRO) | 2025-12-31 | $66.80M | +39.2% |
| Assembly Biosciences, Inc. (ASMB) | 2025-12-31 | $72.30M | +153.5% |
| Bicycle Therapeutics PLC (BCYC) | 2025-12-31 | $72.59M | +105.8% |
| Enanta Pharmaceuticals Inc (ENTA) | 2025-09-30 | $65.32M | -3.4% |
| AbCellera Biologics Inc. (ABCL) | 2025-12-31 | $75.13M | +160.6% |
| Fortress Biotech, Inc. (FBIO) | 2025-12-31 | $63.26M | +9.7% |
Compare RMTI, VRDN, KURA, SPRO side by side · Screen every company in Pharmaceutical Preparations ↗